Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Group Trial Evaluating One Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Tumours of the Testis (NSGCTT)

NCT01726374 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT01726374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01726374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Group Trial Evaluating One Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Tumours of the Testis (NSGCTT)
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2010
Completion date
September 30, 2024
Enrollment
246 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

stage i testicular non-seminomatous germ cell tumor